Development and Validation of UV Spectrophotometric Method for Determination of Milnacipran in bulk and Pharmaceutical Dosage Form
More details
Hide details
K. B. Institute of Pharmaceutical Education and Research, Gandhinagar, 382023, India
Punit B. Parejiya   

K. B. Institute of Pharmaceutical Education and Research, Gandhinagar, 382023, India
Publication date: 2017-10-15
Eurasian J Anal Chem 2011;6(1):53–58
Milnacipran is an antidepressant drug belonging to the class of serotonin and noradrenaline reuptake inhibitors. A new, rapid, simple and sensitive spectrophotometric method has been developed for the determination of milnacipran in bulk and pharmaceutical formulations. The linearity was observed in the concentration range of 2-45 μg mL-1. The method is based on spectrophotometric determinaiton. Absorbance of milnacipran was determined at 220 nm wavelength. The method was validated in terms of accuracy and precision (intra and interday variations). This method is extended to pharmaceutical preparations. Results of the analysis were validated statistically and by recovery studies. The proposed method was found accurate, reproducible and economical for the routine analysis of milnacipran in bulk and pharmaceutical formulation.
Assie M B, Charveron M, Palmier C, Puozzo C, Moret C and Briley M (1992) Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat. Neuropharmacology 31(2):149-55.
Bonnaud B, Cousse H, Mouzon G, Briley M, Stenger A, Fauran F and Couzinier JP (1987) 1-Aryl-2-(aminomethyl) cyclopropanecarboxylic acid derivatives. A new series of potential antidepressants. J Med Chem 30: 318-325.
Stenger A, Couzinier J P and Briley M (1987) Psychopharmacology of milnacipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F2207), a new potential antidepressant. Psychopharmacology 91: 147-153.
Palmier C, Puozzo C, Lenehan T and Briley M. (1989) Monoamine uptake inhibition by plasma from healthy volunteers after single oral doses of the antidepressant milnacipran. Eur J Clin Pharmacol 37: 235-238.
Puech A, Montgomery S A, Prost J F, Solles A and Briley M (1997) Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int Clin Psychopharmacol 12: 99-108.
Christian P, Christian F and Gregoire Z (2004) Determination of milnacipran, a serotonin and noradrenaline reuptake inhibitor, in human plasma using liquid chromatography with spectrofluorimetric detection. J Chromatogr 806: 221–228.
Angela P, Sonia P and Claudia S (2007) Chiral HPLC analysis of milnacipran and its FMOC-derivative on cellulose-based stationary phases. Chirality 20: 63 – 68.
Marie Lecoeur L, Raphael D, Jean Paul R and Philippe M (2008) Chiral analysis of milnacipran by a nonchiral HPLC - circular dichroism: Improvement of the linearity of dichroic response by temperature control. J Separ Sci 31: 3009 – 3014.
The United States Pharmacopeia (2005) The National Formulary 28, US Pharmacopeial Convention Inc., Rockville, MD,USA: 2748-2751.
ICH-Q2R1 Validation of Analytical Procedures: Methodology International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland (1996).
Cazes J. Update Supplement Encyclopedia of Chromatography (2004) Validation of HPLC Instrumentation.339.
Armbruster D A, Tillman M D and Hubbs L M (1994) Comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem 40: 1233-1238.